Ethambutol
Top View
- WHO/CDS/TB/2003.313 Treatment of Tuberculosis: Guidelines for National Programmes, Third Edition Revision Approved by STAG, June 2004
- Critically Important Antimicrobials for Human Medicine – 5Th Revision. Geneva
- Failure with Acquired Resistance of an Optimised Bedaquiline-Based Treatment Regimen for Pulmonary Mycobacterium Avium Complex Disease
- The Use of Bedaquiline in the Treatment of Multidrug-Resistant
- ICCB-L Plate (10 Mm / 3.33 Mm) ICCB-L Well Vendor ID Chemical Name
- The Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in Singapore: Are Patients from South-East Asia Eligible?
- Failure with Acquired Resistance of an Optimised Bedaquiline-Based Treatment Regimen for Pulmonary Mycobacterium Avium Complex Disease
- Tuberculosis Treatment Guidelines
- Synthesis and Evaluation of Mutual Prodrugs of Isoniazid, P-Amino Salicylic Acid and Ethambutol
- Pharmacokinetics and Dosing Rationale of Para
- Part 4 October 2017 Hydrochloride 150Mg/75Mg/400Mg/275Mg Film-Coated Section 7 Updated: April 2020 Tablets, (Micro Labs Limited), TB 223
- Chapter 6 Treatment of Tuberculosis Disease
- TB Regimens and Dose Schedules.Pdf
- E.Johnson Supplementary
- TB Elimination
- Part 4 May 2016 Film-Coated Tablets Suppliers Submission of the (Antibiotice S
- Bedaquiline (Sirturo®)
- An Activist's Guide to Tuberculosis Drugs 2016 Update